Key statistics
On Tuesday, Bruker Corp (BRKR:NSQ) closed at 39.27, 37.64% above the 52 week low of 28.53 set on Sep 03, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 38.68 |
|---|---|
| High | 39.48 |
| Low | 37.58 |
| Bid | 38.86 |
| Offer | 39.62 |
| Previous close | 39.81 |
| Average volume | 2.04m |
|---|---|
| Shares outstanding | 152.22m |
| Free float | 103.36m |
| P/E (TTM) | -- |
| Market cap | 6.06bn USD |
| EPS (TTM) | -0.1485 USD |
| Annual div (ADY) | 0.20 USD |
|---|---|
| Annual div yield (ADY) | 0.50% |
| Div ex-date | Dec 08 2025 |
| Div pay-date | Jan 02 2026 |
Data delayed at least 15 minutes, as of Mar 03 2026 21:00 GMT.
More ▼
- Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR
- Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic Applications
- Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease Biology
- Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum
- Bruker Reports Fourth Quarter and Full Year 2025 Financial Results
- Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC
- Chemspeed and SciY Announce Self‑Driving Laboratory Platform Integrating Automation, Analytics and AI Orchestration
- Bruker Announces Quarterly Preferred Stock Dividend
- Bruker Announces Date and Time of Fourth Quarter 2025 Earnings Release and Webcast
- Bruker Announces $500 Million in Multi-Year Orders from Two Global Healthcare Companies for Supply of High-Performance Superconductors for MRI
More ▼
